Abstract
Purpose
The aim of this study was to evaluate downstaging as primary end point, and progression-free survival and overall survival as secondary end points, in rectal adenocarcinoma patients treated with preoperative chemoradiation.
Methods
One hundred and thirty-six extraperitoneal adenocarcinoma patients (33 low rectum T2, 74 T3, 29 T4 [without sacral invasion], 25 with mucinous subtype) were treated with posterior pelvis preoperative radiotherapy (5040 cGy total dose, 180 cGy/fr, 5 fr/w, 10–15 MV linac X-rays) and concomitant 5-fluorouracil-based chemotherapy. After 6 to 8 weeks patients underwent surgery and prechemoradiation clinical stage was compared with pathologic stage to evaluate downstaging in each patient. Seventy-four patients received adjuvant chemotherapy. Median follow-up was 39 months (4–84).
Results
Forty-four patients had macroscopic complete response, 52 patients had partial response, 37 patients showed no change and 3 patients had progression. At multivariate analysis only histotype showed correlation with downstaging (hazard ratio = 0.350 and 0.138 – 0.885 95 percent confidence interval) because of the evidence for poor downstaging in mucinous subtype. There were no significant differences in overall survival and progression-free survival between adenocarcinoma and mucinous subtype.
Conclusions
The main finding is that mucinous histology is associated with poor downstaging after preoperative chemoradiation but this poor response was not associated with worse outcome in this small study. The good outcome for mucinous histology is at odds with other reports in the literature and requires further study.
Similar content being viewed by others
References
Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553–9.
Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883–8.
Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987–95.
Valentini V, Coco C, Cellini N, et al. Ten years of preoperative chemoradiation for extra peritoneal T3 rectal cancer: acute toxicity, tumour response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001;51:371–83.
Crane CH, Skibber JM, Birnbaum EH, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84–9.
Withers HR, Haustermans K. Where next with preoperative radiation therapy for rectal cancer? Int J Radiat Oncol Biol Phys 2004;58:597–602.
Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer 1989;63:1421–9.
Williamson PR, Hellinger MD, Larach SW, Ferrara A. Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis Colon Rectum 1996;39:45–9.
Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218–24.
Minsky BD. Adjuvant therapy of rectal cancer. Semin Oncol 1999;26:540–4.
Capirci C, Polico C, Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields using new “up down table” device. Int J Radiat Oncol Biol Phys 2001;51:465–73
International Commission on Radiation Units and Measurements. ICRU report 50: prescribing, recording and reporting photon beam therapy. Bethesda, MD: Oxford University Press, 1993
Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott, 1992:1–62
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumour regression after preoperative chemo-radiotherapy of oesophageal carcinoma. Clinic-pathologic correlations. Cancer 1994;73:2680–6.
Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457–81.
Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187–220.
Sobin LH, Wittekind Ch, eds. UICC International Union Against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002
Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy for rectal cancer. Predictive factors of tumor downstaging and residual tumor cell density. Prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619–27.
Kaminsky-Forret MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935–41.
Janjan NA, Abbruzzese J, Pazdur R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 1999;51:153–60.
Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of post-chemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075–80.
Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002;53:664–74.
Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94:1121–30.
Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891–900.
Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000;75:103–7.
Secco GB, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994;51:30–4
Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 2000;73:70–4
Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Pathology Review Committee. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002;197:20–7
Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB, Ray JE. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum 1993;36:49–54
Jessup JM, Loda M, Bleday R. Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer. Semin Radiat Oncol 1998;8:54–69.
Hussain SM, Outwater EK, Siegelman ES. MR imaging features of pelvic mucinous carcinomas. Eur Radiol 2000;10:885–91.
Hussain SM, Outwater EK, Siegelman ES. Mucinous vs. non mucinous rectal carcinomas: differentiation with MR imaging. Radiology 1999;213:79–85.
Kim MJ, Park JS, Park SI, et al. Accuracy in differentiation of mucinous and non mucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr 2003;27:48–55.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Grillo-Ruggieri, F., Mantello, G., Berardi, R. et al. Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative Chemoradiotherapy. Dis Colon Rectum 50, 1594–1603 (2007). https://doi.org/10.1007/s10350-007-9026-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-9026-1